Articles related to BREAST CANCER

Highlighting a paradigm shift in breast cancer treatment, the NRG Oncology/NSABP B-51/RTOG 1304 study demonstrates that certain patients with node-negative breast cancer post-neoadjuvant chemotherapy may safely omit adjuvant regional nodal irradiation, challenging conventional treatment approaches and potentially improving patient quality of life.

Explore the latest findings from SABCS 2023 on the role of fusion RNAs in therapy resistance and the impact of new investigational therapies on metastatic breast cancer treatment.

AI’s transformative role in breast cancer care goes beyond prediction—it offers a nuanced evaluation of both cancerous and non-cancerous elements, guiding individualized treatment plans. Learn how this innovation minimizes unnecessary chemotherapy, prioritizes patient outcomes, and heralds a new era in precision medicine.

In a recent study, researchers found that vaginal estrogen therapy does not increase the risk of death in patients with breast cancer. In fact, it may even decrease the risk of breast cancer-specific death and all-cause death.

Did you know that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery not only provides the same protection against breast cancer recurrence but also substantially reduces life disruption and financial burden for patients?

This study provides compelling evidence on the role of adjuvant chemotherapy in hormone-receptor–positive, HER2-negative breast cancer with positive lymph nodes, revealing a significant impact based on menopausal status.